Joseph S. Zakrzewski - 07 Dec 2022 Form 4/A - Amendment Insider Report for Cyteir Therapeutics, Inc.

Role
Director
Signature
/s/ Adam M. Veness, as attorney-in-fact for Joseph Zakrzewski
Issuer symbol
N/A
Transactions as of
07 Dec 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
08 Dec 2022, 20:17:50 UTC
Date Of Original Report
08 Dec 2022
Previous filing
16 May 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CYT Common Stock 213,289 07 Dec 2022 Direct F1, F2
holding CYT Common Stock 149,051 07 Dec 2022 See Footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4 filed on December 8, 2022 reported securities in column 5 of Table I as indirectly beneficially owned by the Reporting Person through Z Investments, LLC, but these securities were previously transferred to the Reporting Person and should have been reported as directly beneficially owned by the Reporting Person.
F2 27,551 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
F3 Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.

Remarks:

As noted in Footnote 1, this Form 4/A amends the Form 4 filed on December 8, 2022 for this Reporting Person.